NuVasive vows to fight Medtronic's latest patent blitz

NuVasive vows to "vigorously" defend against Medtronic's latest claims in a long-running patent-infringement row over spinal devices.

NuVasive Inc. [1] (NSDQ:NUVA [2]) is prepared to go another round in the long-running spinal patent battle against Medtronic [3] (NYSE:MDT [4]).

NuVasive vowed to "vigorously" defend itself against the latest accusations of patent infringement that Medtronic filed in an Indiana District Court earlier this month.

"NuVasive is assessing all offensive and defensive measures available to it, including the assertion of counterclaims and the use of administrative reexamination procedures available through the U.S. Patent & Trademark Office," according to a company statement.